InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
61,316.03
(
0.69%
)
Post# of 110672
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Elroy Jetson

Send PM Follow Ignore
Followers 38
Posts 13290
Boards Moderated 0
Alias Born 07/09/2002

Elroy Jetson

Member Level

Re: santafe2 post# 106074

Thursday, 05/18/2023 1:52:00 PM

Thursday, May 18, 2023 1:52:00 PM

Post# of 110672
Pfizer PFE will complete a $31 billion debt offering tomorrow, to fund its pending $43 billion acquisition of (ADC) antibody-drug conjugate maker, Seagen SGEN. The bond sale is one of the largest debt offerings of all time.


Seagen has four approved drugs and a large pipeline of additional cancer ADCs - https://www.seagen.com/science/pipeline

The acquisition for $229 per share, an 18% premium to the current SGEN price, should gain regulatory approval and close later this year.

SGEN will immediately increase Pfizer's revenue, up $30 billion by 2030, and will be initially slightly profit accretive, which will grow over time.


Seagen was founded in 1998 as Seattle Genetics.

We've run out of other people's Social Security taxes needed to subsidize our low income tax rates.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up